fingolimod
Showing 1 - 25 of 50
Intracerebral Hemorrhage Trial (Fingolimod)
Not yet recruiting
- Intracerebral Hemorrhage
- Fingolimod
- (no location specified)
Oct 17, 2023
Chemo-Induced Peripheral Neuropathy, Numbness, Pain Trial in Rochester, Columbus (Fingolimod, Fingolimod Hydrochloride,
Active, not recruiting
- Chemotherapy-Induced Peripheral Neuropathy
- +3 more
- Fingolimod
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 17, 2023
Breast Carcinoma Trial in Rochester, Columbus, Richmond (Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration)
Active, not recruiting
- Breast Carcinoma
- Fingolimod
- +2 more
-
Rochester, Minnesota
- +2 more
Jul 6, 2022
Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)
Enrolling by invitation
- Interstitial Fibrosis
- +6 more
- Fingolimod
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Jan 23, 2023
Stroke Inflammation Trial in Fuzhou (Fingolimod)
Recruiting
- Stroke Inflammation
- Fingolimod
-
Fuzhou, ChinaThe First Affiliated Hospital of Fujian Medical University
Apr 12, 2022
Generic Fingolimod in Relapsing-Remitting Multiple Sclerosis in
Recruiting
- Relapsing-Remitting Multiple Sclerosis
- Fingolimod
-
Alexandria, Egypt
- +1 more
Jun 14, 2022
Diabetes, Type 2 Trial in Shenyang (Fingolimod, guideline-based treatment for DM)
Recruiting
- Diabetes Mellitus, Type 2
- Fingolimod
- guideline-based treatment for DM
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Mar 31, 2022
Impact of Fingolimod Adherence on Outcomes
Completed
- Multiple Sclerosis
- Fingolimod
-
East Hanover, New JerseyNovartis Investigational Site
Dec 15, 2021
Stroke, Inflammation Trial in Hangzhou (Fingolimod)
Withdrawn
- Stroke
- Inflammation
- Fingolimod
-
Hangzhou, Zhejiang, ChinaThe second affiliated hospital of Zhejiang University
Jul 15, 2021
Relationship Between Oral DMT Burden and Adherence in MS
Enrolling by invitation
- Multiple Sclerosis
- Adherence, Medication
- Cladribine
- +5 more
-
Melbourne, Victoria, AustraliaMonash University
Aug 28, 2022
Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +8 more
-
Eden Prairie, MinnesotaOptumInsight
Jan 9, 2023
Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)
Recruiting
- Multiple Sclerosis (MS)
- Fingolimod
- +5 more
-
Little Rock, Arkansas
- +55 more
Jan 13, 2023
Stroke, Inflammation Trial in Hangzhou (Fingolimod, Placebo)
Unknown status
- Stroke
- Inflammation
- Fingolimod
- Placebo
-
Hangzhou, Zhejiang, ChinaThe second affiliated hospital of Zhejiang University
Jul 17, 2021
Stroke Trial (Fingolimod, )
Not yet recruiting
- Stroke
- Fingolimod
- placebo
- (no location specified)
Jan 17, 2021
Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)
Recruiting
- Multiple Sclerosis
- Interferon beta-1a
- +3 more
-
Birmingham, Alabama
- +106 more
Jan 13, 2023
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)
Recruiting
- Relapsing-Remitting Multiple Sclerosis
- Ocrelizumab
- +3 more
-
La Jolla, California
- +66 more
Jan 27, 2023
Relapsing Multiple Sclerosis Trial in United States (Fingolimod)
Completed
- Relapsing Multiple Sclerosis
- Fingolimod
-
Birmingham, Alabama
- +65 more
Oct 6, 2021
Relapsing Remitting Multiple Sclerosis Trial in Milan (Fingolimod, Dimethyl Fumarate)
Terminated
- Relapsing Remitting Multiple Sclerosis
- Fingolimod
- Dimethyl Fumarate
-
Milan, ItalyFondazione IRCCS Istituto Neurologico C. Besta, Neuroimmunology
Oct 29, 2019
Multiple Sclerosis Treated Fingolimod or Other Approved
Completed
- Multiple Sclerosis
- other disease-modifying therapy
- Fingolimod
-
Birmingham, Alabama
- +237 more
Dec 28, 2021
Relapsing Remitting Multiple Sclerosis Trial in Puerto Rico, United States (Fingolimod, Disease Modifying therapy)
Completed
- Relapsing Remitting Multiple Sclerosis
- Fingolimod
- Disease Modifying therapy
-
Cullman, Alabama
- +122 more
Dec 9, 2020
Relapsing Remitting Multiple Sclerosis RRMS Trial in Germany, Switzerland (Fingolimod)
Completed
- Relapsing Remitting Multiple Sclerosis RRMS
- Fingolimod
-
Bochum, Germany
- +9 more
Feb 14, 2020
Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)
Completed
- Relapsing Forms of Multiple Sclerosis
- Fingolimod
-
Cullman, Alabama
- +457 more
Mar 26, 2021